| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1998;98:2534-2537.)
© 1998 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Departments of Virology (M.R., M.K., T.H.), Nutrition (G.A.), and Epidemiology and Health Promotion (P.J., J.T.), National Public Health Institute, Helsinki, Finland.
Correspondence to Prof Jaakko Tuomilehto, Department of Epidemiology and Health Promotion, National Public Health Institute, Mannerheimintie 166, FIN-00300 Helsinki, Finland. E-mail jaakko.tuomilehto{at}ktl.fi
BackgroundAn increasing body of evidence suggests that, in addition to the well-known classic risk factors, some microbial infections may be associated with the development of atherosclerosis and myocardial infarction (MI). The aim of our study was to evaluate the possible role of enteroviral infections in the pathogenesis of MI.
Methods and ResultsStored sera, collected in Eastern Finland in 1977, from a set of 12 155 randomly selected men and women aged 25 to 64 years were used in prospective, nested case-control study. The study sample comprised 183 men and 81 women with MI and matched controls. The sera were tested for IgG antibodies to a newly identified enterovirus-common (EVC) antigen, to heat-denatured coxsackievirus B5 (CBV-5), and to adenovirus hexon protein. Raw data from enzyme immunoassays were converted to relative units before analysis. In univariate analysis, EVC antibodies were significantly associated with the risk of MI in men (P=0.009) but not in women. Men with MI had a significantly higher mean level of EVC antibodies than matched controls (P=0.014). High antibody levels to EVC were associated with an increased risk of MI in men aged 25 to 49 years (relative risk [RR] 4.34, P<0.001) but not in older men (>50 years of age). Women with MI also showed a trend toward higher antibody levels than control women, but the difference was not statistically significant. Antibody levels to whole CBV-5 or adenovirus hexon protein appeared to be no different among case patients versus control subjects.
ConclusionsIf we assume that a high level of EVC antibodies reflects a history of relatively frequent enterovirus infections, the present observation might suggest that enterovirus infections increase the risk of MI at least in middle-aged men. Further studies are needed to understand possible clinical significance of this observation.
Key Words: viruses myocardial infarction follow-up studies
This article has been cited by other articles:
![]() |
H. Al-Hello, A. Paananen, M. Eskelinen, P. Ylipaasto, T. Hovi, K. Salmela, A. N. Lukashev, S. Bobegamage, and M. Roivainen An enterovirus strain isolated from diabetic child belongs to a genetic subcluster of echovirus 11, but is also neutralised with monotypic antisera to coxsackievirus A9 J. Gen. Virol., August 1, 2008; 89(8): 1949 - 1959. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Andreoletti, L. Venteo, F. Douche-Aourik, F. Canas, G. L. de la Grandmaison, J. Jacques, H. Moret, N. Jovenin, J.-F. Mosnier, M. Matta, et al. Active Coxsackieviral B Infection Is Associated With Disruption of Dystrophin in Endomyocardial Tissue of Patients Who Died Suddenly of Acute Myocardial Infarction J. Am. Coll. Cardiol., December 4, 2007; 50(23): 2207 - 2214. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Fernandez-Real, A. Lopez-Bermejo, J. Vendrell, M.-J. Ferri, M. Recasens, and W. Ricart Burden of Infection and Insulin Resistance in Healthy Middle-Aged Men Diabetes Care, May 1, 2006; 29(5): 1058 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. T Keller, A. T.A Mairuhu, M. D de Kruif, S. K Klein, V. E.A Gerdes, H. ten Cate, D. P.M Brandjes, M. Levi, and E. C.M van Gorp Infections and endothelial cells Cardiovasc Res, October 15, 2003; 60(1): 40 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. J de Boer, A. E Becker, and A. C van der Wal T lymphocytes in atherogenesis--functional aspects and antigenic repertoire Cardiovasc Res, October 15, 2003; 60(1): 78 - 86. [Full Text] [PDF] |
||||
![]() |
P Jousilahti, V Salomaa, V Rasi, E Vahtera, and T Palosuo Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status J Epidemiol Community Health, September 1, 2003; 57(9): 730 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Smieja, J. Gnarpe, E. Lonn, H. Gnarpe, G. Olsson, Q. Yi, V. Dzavik, M. McQueen, S. Yusuf, and for the Heart Outcomes Prevention Evaluation (HOPE Multiple Infections and Subsequent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study Circulation, January 21, 2003; 107(2): 251 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Pussinen, T. Vilkuna-Rautiainen, G. Alfthan, K. Mattila, and S. Asikainen Multiserotype Enzyme-Linked Immunosorbent Assay as a Diagnostic Aid for Periodontitis in Large-Scale Studies J. Clin. Microbiol., February 1, 2002; 40(2): 512 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Boman and M. R. Hammerschlag Chlamydia pneumoniae and Atherosclerosis: Critical Assessment of Diagnostic Methods and Relevance to Treatment Studies Clin. Microbiol. Rev., January 1, 2002; 15(1): 1 - 20. [Abstract] [Full Text] |
||||
![]() |
C. Basso, F. Calabrese, D. Corrado, and G. Thiene Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings Cardiovasc Res, May 1, 2001; 50(2): 290 - 300. [Full Text] [PDF] |
||||
![]() |
S A Morre, W Stooker, W K Lagrand, A J C van den Brule, and H W M Niessen Microorganisms in the aetiology of atherosclerosis J. Clin. Pathol., September 1, 2000; 53(9): 647 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.J. Mattila, S. Asikainen, J. Wolf, H. Jousimies-Somer, V. Valtonen, and M. Nieminen Age, Dental Infections, and Coronary Heart Disease Journal of Dental Research, February 1, 2000; 79(2): 756 - 760. [Abstract] [PDF] |
||||
![]() |
M. Roivainen, M. Viik-Kajander, T. Palosuo, P. Toivanen, M. Leinonen, P. Saikku, L. Tenkanen, V. Manninen, T. Hovi, and M. Manttari Infections, Inflammation, and the Risk of Coronary Heart Disease Circulation, January 25, 2000; 101(3): 252 - 257. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |